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Depression	  in	  newly	  diagnosed	  type	  2	  diabetes	  is	  associated	  with	  raised	  levels	  of	  systemic	  	  
inflammatory	  markers.	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Background	  and	  aims:	  There	  is	  an	  increased	  prevalence	  of	  depression	  in	  type	  2	  diabetes	  mellitus	  
(T2DM)	  which	  is	  associated	  with	  more	  frequent	  diabetes	  complications	  and	  increased	  mortality.	  
T2DM	  and	  macrovascular	  disease	  are	  independently	  associated	  with	  raised	  levels	  of	  circulating	  
inflammatory	  markers	  and	  in	  non-­‐diabetes	  participants	  there	  is	  evidence	  that	  depression	  is	  linked	  
with	  inflammation.	  Since	  inflammation	  may	  be	  the	  common	  antecedent	  of	  both	  T2DM	  and	  
depression	  and	  may	  play	  a	  pathogenic	  role,	  we	  tested	  the	  hypothesis	  that	  patients	  with	  new-­‐onset	  
T2DM	  and	  depression	  have	  higher	  levels	  of	  circulating	  inflammatory	  markers	  than	  T2DM	  patients	  
without	  depression.	  
	  
Materials	  and	  methods:	  Adults	  with	  newly	  diagnosed	  T2DM	  recruited	  from	  primary	  care	  were	  
assessed	  for	  depression	  using	  the	  Patient	  Health	  Questionnaire-­‐9	  (PHQ-­‐9).	  Markers	  of	  inflammation	  
were	  measured	  from	  fasting	  blood	  samples	  and	  included:	  high	  sensitivity	  C-­‐reactive	  protein	  (hs-­‐
CRP),	  white	  blood	  cell	  count	  (WBC),	  interleukin-­‐1	  receptor	  antagonist	  (IL-­‐1RA).	  Covariates	  included	  
socio-­‐demographic	  factors,	  adiposity,	  smoking	  and	  HbA1C.	  Univariate	  analyses	  were	  used	  to	  
determine	  relationships	  between	  depression	  and	  inflammatory	  markers	  and	  multiple	  linear	  
regressions	  were	  used	  to	  adjust	  for	  covariates.	  
	  
Results:	  1489	  data	  sets	  were	  available	  for	  analysis;	  mean	  [SD]	  age	  =	  55.4	  [11.2]	  years,	  44.9%	  female,	  
prevalence	  of	  depression	  =	  14.7%.	  Depressed	  participants	  were	  younger	  at	  diagnosis	  (mean	  [SD]	  age	  
=	  52	  [9.9]	  vs.	  56	  [11.2]	  years,	  p	  <0.001)	  but	  had	  similar	  HbA1C	  (mean	  [SD]	  HbA1C	  =	  7.0	  [1.5]	  vs.	  7.2	  
[1.5]	  %).	  Inflammatory	  markers	  were	  significantly	  increased	  in	  depressed	  compared	  to	  non-­‐
depressed	  participants;	  median	  [IQR]	  hs-­‐CRP	  =	  3.4	  [1.5	  -­‐	  8.9]	  vs.	  2.6	  [1.1	  -­‐	  6.2]	  mg/L,	  p=0.002;	  
median	  [IQR]	  WBC	  =	  7.1	  [5.7	  -­‐	  8.6]	  vs.	  6.5	  [5.3	  -­‐7.9]	  x109/L,	  p	  <	  0.001;	  median	  [IQR]	  IL-­‐1RA	  =	  501.6	  
[334.6	  -­‐	  786.3]	  vs.	  435.4	  [292.0	  -­‐	  678.2]	  ng/L,	  p	  =	  0.004.	  Associations	  between	  levels	  of	  inflammatory	  
markers	  and	  depressive	  symptoms	  remained	  after	  adjusting	  for	  covariates:	  hs-­‐CRP	  (standardised	  b	  =	  
0.10,	  p	  =	  0.002),	  WBC	  (standardised	  b	  =	  0.11,	  p	  <	  0.001),	  IL-­‐1RA	  (standardised	  b	  =	  0.13,	  p	  <	  0.001).	  
After	  one	  year	  inflammatory	  markers	  remained	  significantly	  increased	  in	  participants	  who	  were	  
depressed	  at	  baseline	  compared	  with	  participants	  who	  were	  not	  depressed	  at	  baseline:	  median	  
[IQR]	  hs-­‐CRP	  =	  3.5	  [1.3	  -­‐	  7.9]	  vs.	  2.2	  [0.9	  -­‐	  5.0]	  mg/L,	  p	  <	  0.001.	  This	  association	  also	  remained	  after	  
adjusting	  for	  covariates:	  hs-­‐CRP	  (standardised	  b	  =	  0.11,	  p	  <	  0.001).	  In	  those	  who	  were	  depressed	  at	  
baseline	  after	  twelve	  months	  there	  was	  no	  difference	  in	  levels	  of	  inflammatory	  markers	  between	  
those	  with	  improved	  depressive	  symptoms	  and	  those	  without.	  
	  
Conclusion:	  Circulating	  markers	  of	  inflammation	  are	  significantly	  elevated	  in	  T2DM	  participants	  with	  
depression	  compared	  to	  non-­‐depressed	  T2DM	  participants,	  these	  levels	  are	  still	  raised	  12	  months	  
later.	  These	  consistently	  increased	  levels	  of	  inflammation	  and	  activated	  innate	  immunity	  observed	  in	  
T2DM	  with	  depression	  may	  help	  to	  explain	  the	  persistent	  increased	  risk	  of	  complications	  and	  
mortality	  in	  this	  group.	  
	  
